Bioequivalence and Bioavailability Forum

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log-in |  Register |  Search

Back to the forum  Query: 2017-11-18 21:29 UTC (UTC+2h)
 

ULOQ [Study As­sess­ment]

posted by Anand - India, 2017-10-30 05:38  - Posting: # 17945
Views: 629

Dear All,

Request to clarify,

In our Pivotal BE Study ULOQ was observed, whether we should exclude from PK?
After Dilution also it found ULOQ.
Method should be redeveloped or revalidated?
If included,What justification we should provide to Regulatory Agency?

Thanks in advance.

Regards,
A.A


Edit: Category changed; see also this post #1. [Helmut]

Complete thread:

Back to the forum Activity
 Mix view
Bioequivalence and Bioavailability Forum | Admin contact
17,482 Posts in 3,743 Threads, 1,085 registered users;
24 users online (0 registered, 24 guests).

I have had my results for a long time:
but I do not yet know how I am to arrive
at them.    Carl Friedrich Gauss

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
XHTML/CSS RSS Feed